| Women (n = 64) | Men (n = 24) |  | ||||
---|---|---|---|---|---|---|---|
Mean | % below | % above | Mean | % below | % above | Reference | |
 |  | Reference |  | Reference | Range | ||
White blood cell count (×109/L) | 7.0 ± 1.6 | 1.6 |  | 7.7 ± 2.3 |  | 8.3 | 4–11 |
Total lymphocytes (×109/L) | 1.6 ± 0.4 | 4.7 |  | 1.5 ± 0.5 | 12.5 |  | 1.0–4.0 |
Neutrophils (×109/L) | 4.5 ± 1.3 |  |  | 5.1 ± 1.9 |  | 8.3* | 2.0–8.0 |
Monocytes (×109/L) | 0.6 ± 0.2 |  | 6.2 | 0.7 ± 0.2 |  | 12.5 | 0.0–1.0 |
CD3 + (total T cells) | |||||||
Count (×106/L) | 1174 ± 338 | 6.2 |  | 1021 ± 355 | 16.7 |  | 688–2445 |
Percentage | 73.5 ± 8.5 | 4.7 | 9.4 | 70.8 ± 7.8 | 8.3 | 8.3 | 59–84 |
CD3 + CD4 + (CD4 + T cells) | |||||||
Count (×106/L) | 824 ± 279 |  |  | 697 ± 239* | 8.3* |  | 389–1569 |
Percentage | 51.5 ± 10.5 |  | 18.8 | 47.1 ± 7.3 |  | 4.2 | 31–59 |
CD3 + CD8 + (CD8 + T cells) | |||||||
Count (×106/L) | 329 ± 160 | 8 |  | 292 ± 151 | 21 |  | 168–894 |
Percentage | 20.2 ± 7.9 | 12.5 |  | 20.1 ± 8.1 | 12.5 |  | 12–42 |
CD4 + :CD8 + ratio | 2.8 ± 1.4 |  |  | 2.8 ± 1.4 |  |  |  |
CD19 (B-cells) | |||||||
Count (×106/L) | 145 ± 85 | 35.9 |  | 109 ± 73 | 45.8 |  | 98–597 |
Percentage | 8.9 ± 4.6 | 29.7 |  | 7.3 ± 3.9 | 41.7 |  | 6–26 |
CD3 − CD16 + CD56 + (NK cells) | |||||||
Count (×106/L) | 266 ± 122 | 1.6 |  | 291 ± 129 |  |  | 61–776 |
Percentage | 16.7 ± 6.5 | 4.7 | 6.3 | 20.2 ± 7.9* | 4.2 | 12.5 | 7–28 |
NK: CD4 + T ratio | 0.35 ± 0.20 |  |  | 0.45 ± 0.22 * |  |  |  |